Zentalis Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: ZNTL
Share price (11/13/26): $1.70
Market cap (11/13/26): $167 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Registration of securities for employees

Ownership Filter

Walters Group, Walters William Thurman, Walters Susan Berkley

News Filter

Reports Third Quarter 2026 Financial Results and Business Updates

Other Events, Financial Statements or Exhibits

Reports Second Quarter 2026 Financial Results and Business Updates

Shareholder Vote Results

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC